Clinical Trials Logo

Filter by:
NCT ID: NCT03083444 Withdrawn - Clinical trials for Tooth Eruption, Atherosclerosis

P Gingivalis Oral Infection, Intimamedia Thickening in Infants, Atherosclerosis

Start date: April 15, 2017
Phase: N/A
Study type: Observational

To determine if there is an association between Porphyromonas gingivalis infection of dental gingiva during primary tooth eruption and thickening of the radial artery intimamedial layers. Thickening of these layers in infants could be a promoting factor for later development of atherosclerosis.

NCT ID: NCT03083340 Withdrawn - MDD Clinical Trials

Implementation of a Self-Help Depression Program Among Orthopedic Patients

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The proposed study addresses the potential utility of providing an accessible self-help intervention for patients in a medical setting with an estimated diagnosis of MDD. Specifically, the study will explore whether a) such an intervention can be effectively implemented in a primary care setting and b) patients originally seeking medical attention for an orthopedic problem will be willing to seek psychological treatment and, c) improvement in depression symptoms will lead to improvement in upper and lower extremity functioning.

NCT ID: NCT03082157 Withdrawn - Weight Loss Clinical Trials

Mighty Men Nashville: A Faith-Based Weight Loss Program to Address Cancer Disparities

Start date: October 27, 2017
Phase: N/A
Study type: Interventional

Mighty Men is a 6-month faith-based weight-loss intervention for obese African American men 35-74 years old being conducted in Nashville, TN.

NCT ID: NCT03081169 Withdrawn - Clinical trials for TBI (Traumatic Brain Injury)

Timing of VTE Prophylaxis in TBI

Start date: April 3, 2017
Phase: Phase 4
Study type: Interventional

This study compares the efficacy and complication rates of early (24 hours) versus late (72 hours) VTE prophylaxis administration to TBI patients. Patients in both treatment groups will be monitored for development of VTE as well as complications from bleeding after commencement of VTE prophylaxis.

NCT ID: NCT03081039 Withdrawn - Clinical trials for Intrahepatic Cholangiocarcinoma

A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

Start date: August 21, 2017
Phase: Phase 3
Study type: Interventional

Compare the efficacy of adjuvant chemotherapy with Cisplatin or Carboplatin and Gemcitabine versus Gemcitabine in patients with resected or ablated intra-hepatic cholangiocarcinoma.

NCT ID: NCT03079973 Withdrawn - Nail Psoriasis Clinical Trials

Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s

Start date: May 15, 2017
Phase: Phase 3
Study type: Interventional

The objective of this phase III study is to evaluate the efficacy, systemic safety and local tolerability of P-3073 (calcipotriene 0.005%) nail solution in patients with mild to moderate psoriatic fingernail/s.

NCT ID: NCT03077477 Withdrawn - Neoplasms Clinical Trials

Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers

Start date: June 12, 2018
Phase: Phase 1
Study type: Interventional

This is a Phase 1 study, which will assess the safety, PK, and pharmacodynamics (PD) of orally-administered AMXT 1501 dicaprate in normal healthy male volunteers. The study is comprised of a total of 8 cohorts; 4 single ascending dose (SAD) cohorts, 1 Food Effect (FE) Crossover cohort, and 3 multiple ascending dose (MAD) cohorts. Tablets will be administered after an overnight fast (10 hours) with at least 250 mL water. No food will be administered (exception for "fed" subjects, see below) for one hour thereafter. Each cohort will have a total 6 subjects: SAD and MAD (2 subjects receiving placebo and 4 subjects receiving active AMXT 1501 dicaprate); and FE crossover (6 subjects receiving active AMXT 1501 dicaprate).

NCT ID: NCT03077022 Withdrawn - Clinical trials for Femoroacetabular Impingement

Femoroacetabular Impingement (FAI): The Effectiveness of Physical Therapy

Start date: February 2016
Phase:
Study type: Observational

The treatment of femoroacetabular impingement has evolved over the last several years. As the number of arthroscopic hip operations has risen over the last few years, so has the level controversy in regards to the appropriate initial management. There have been many recent advances in clinical diagnosis, advanced imaging techniques, improved indications for surgery and improved arthroscopic techniques which have led to improved clinical outcomes, but the effectiveness of physical therapy remains unknown.

NCT ID: NCT03076710 Withdrawn - Analgesia Clinical Trials

Post-Operative Pain Management Following Spine Surgery

EXPAREL
Start date: July 31, 2017
Phase:
Study type: Observational

The primary objective of this pilot study is to assess the feasibility of comparing two standardized approaches to manage post-operative pain following spine surgery: one approach using Patient Controlled Analgesia (PCA) devices to deliver opioid analgesics, and the other approach using EXPAREL® infiltration at the site of surgery and nurse-administered opioid analgesics.

NCT ID: NCT03076684 Withdrawn - Hyperuricemia Clinical Trials

Gender Differences in the Metabolic Effects of Uric Acid

Start date: March 3, 2017
Phase: Early Phase 1
Study type: Interventional

Increased stiffening of the heart and blood vessels is a predictor of heart disease. Stiffening has been found to be greater in women than men, which puts women with poor blood sugar control at a greater risk for heart disease than men. In women only, a molecule in the blood called uric acid can be elevated due to diets high in fructose consumption and it is thought to be a cause of heart and vessel stiffening. From previous research, we have found that restricting fructose in the diet lowers uric acid more in women than men. There is also a drug that can be used to lower uric acid. These findings suggest a potential approach to decrease vessel and heart stiffness in women. The present study will investigate fructose restriction in the diet and drug treatment to lower uric acid in the blood and its effects on heart disease risk in women compared to men.